FDC launches Favipiravir oral suspension

Convenient loading dosage of the oral suspension helps reduce dosage frequency, it added.

77
Medicine Syrup
Picture: Pixabay

Last Updated on July 14, 2021 by The Health Master

FDC has launched oral suspension of Favipiravir to treat mild to moderate cases of C-19 in the country.

This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement.

Convenient loading dosage of the oral suspension helps reduce dosage frequency, it added.

“With positive cases on the rise again, now is the time to provide healthcare warriors in our country with viable options in this continuous battle against this disease.

In order to combat C-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of C-19 treatment hassle-free,” said Mayank Tikkha,  General Manager – Business Development & Commercial Excellence, FDC.

Lupin launches generic drug to treat HIV 1 infection

Dr Reddy’s Lab commercially launches 2DG

Dr. Reddy’s Labs launches Icosapent Ethyl Capsules

Cadila Pharma launches Posaconazole to treat fungal diseases

Cipla launches Vitamin C Chewable Tablets with Gold Supplement

Glenmark launches drug to treat Pulmonary disease in UK

Latest Notifications: EC Act (Essential Commodities Act)

NABL: List of NABL Accredited Testing Laboratories

NPPA fixes retail prices of 11 formulations

Fake Syrup supplying Racket busted with one arrest

MBBS interns will have to take Ayush training: NMC

Alert: Various chemicals in Cosmetics: Must read

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner